The protein tyrosine phosphatase SHP2 (encoded by PTPN11) mediates the activation of the MAPK and PI3K signaling cascades, and pharmacologic inhibition or depletion of SHP2 suppresses tumor growth in several cancer models, including neuroblastoma (28–30). This evidence concerns the gene PTPN11 and neuroblastoma.